动脉橙：2025年9月全球医疗健康领域投融资月报

Summary of Key Points Core Viewpoint - In September 2025, the global healthcare sector experienced a significant increase in financing activities, with a total of 175 financing events and a disclosed total amount of approximately $10.188 billion (about 727.16 billion RMB), marking a substantial growth compared to previous months [7][8][9]. Financing Overview - A total of 175 financing events occurred in September 2025, with 68 events in the domestic market amounting to approximately $9.56 million and 107 events overseas totaling about $92.32 million, indicating a strong overseas market presence [7][8]. - The financing scale saw a month-on-month increase of approximately 183.09%, with the number of events rising by about 15.13% compared to August [9][10]. Sector Performance - The biopharmaceutical sector had the highest number of financing events, totaling 73 (41.71% of the total), while the digital health sector attracted the highest financing amount of $5.773 billion (56.67% of the total) [15][16]. - Notable large financing events included Shields Health Solutions, which secured $3.5 billion, and Kriya Therapeutics, which raised $320 million for chronic disease gene therapy [10][15]. Financing Distribution - The financing rounds were predominantly in the A round (31%), followed by B round (18%), and undisclosed rounds (17%), indicating a strong activity in early and growth-stage financing [14][15]. - The funds raised were primarily allocated for clinical trial advancements, product development and commercialization, global market expansion, and technology platform upgrades [15]. Major Financing Events - Significant financing events included: - Shields Health Solutions raised $3.5 billion to enhance its pharmacy services [33]. - Kriya Therapeutics completed a $320 million D round for gene therapy development [25]. - Strive Health raised $550 million for remote kidney care services [27]. - Oura Health secured $875 million for global expansion of its smart ring technology [21]. - Galvanize Therapeutics raised $100 million for its medical device technology [32]